- $82.63m
- $389.87m
- $156.27m
Annual income statement for Stem, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 127 | 363 | 462 | 145 | 156 |
| Cost of Revenue | |||||
| Gross Profit | 1.25 | 33.1 | 3.67 | -10.3 | 62 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 216 | 494 | 582 | 984 | -8.09 |
| Operating Profit | -88.1 | -131 | -120 | -839 | 164 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -101 | -139 | -140 | -854 | 138 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -101 | -124 | -140 | -854 | 138 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -101 | -124 | -140 | -854 | 138 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -101 | -124 | -140 | -854 | 138 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -17.3 | -15.4 | -22.4 | -57.9 | 0.091 |